The protracted battle over transcatheter heart valves between Medtronic Inc. (NYSE:MDT) and Edwards Lifesciences Inc. (NYSE:EW) will be decided in the streets rather than the courts.

Medtronic Inc. (NYSE:MDT) managed to find the silver lining in the dark cloud that is a $74 million patent infringement judgment against it when a federal judge denied an Edwards Lifesciences Inc. (NYSE:EW) move to bar U.S. manufacturing and sales of its CoreValve aortic valve replacement.

Edwards Lifesciences Corp. (NYSE:EW) revealed yesterday a U.S. Attorney’s Office for Central California subpoena for documents related to its 2006 heart monitor recall.The Irvine, California-based cardiac device maker said the court communication came “in connection with an investigation by the federal Food & Drug Administration,” and sought “records relating to [...]

Edwards Lifesciences Corp. got a boost this week after the New England Journal of Medicine published a study showing that the company’s catheter-delivered aortic valve replacement is much safer for elderly patients than standard treatments. Edwards and Fridley, Minnesota-based Medtronic (and other companies) are racing to get the first percutaneous heart valves to market.

Medtronic Inc. lost the latest round in a long-running legal dispute when a jury found that its CoreValve heart valve system infringes on patents held by Edwards Lifecsciences Inc.The case is far from over, however, as Medtronic said it would appeal the jury’s verdict, which awarded Edwards $74 million in damages. Edwards plans to seek [...]

The FDA posted notice of a Class I recall of a hemodialysis system distributed by Baxter International Inc., warning that in extreme cases the machine’s defect could result in serious injuries or death.